Abstract:In cells of the myeloid lineage, NLRP3 stimulation leads to disassembly of the trans‐Golgi network (TGN). The resulting dispersed TGN serves as a scaffold for NLRP3 aggregation, leading to cytokine production and pyroptosis. In contrast, it is proposed that the magnitude of interactions between the polybasic motif of NLRP3 and the TGN in adaptive immunity is low, which triggers cytokine production, but does not result in pyroptotic cell death. Eukaryotic cells are equipped with cytoplasmic sensors that recognize diverse pathogen‐ or danger‐associated molecular patterns. In cells of the myeloid lineage, activation of these sensors leads to the assembly of a multimeric protein complex, called the inflammasome, that culminates in the production of inflammatory cytokines and pyroptosis. Recently, investigation of the inflammasomes in lymphocytes led to the discovery of functional pathways that were initially believed to be confined to the innate arm of the immune system. Thus, the adapter protein apoptosis‐associated speck‐like protein containing a CARD (ASC) was documented to play a critical role in antigen uptake by dendritic cells, and regulation of T‐ and B‐cell motility at several stages, and absent in melanoma 2 (AIM2) was found to act as a modulator of regulatory T‐cell differentiation. Remarkably, NLRP3 was demonstrated to act as a transcription factor that controls Th2 cell polarization, and as a negative regulator of regulatory T‐cell differentiation by limiting Foxp3 expression. In B lymphocytes, NLRP3 plays a role in the transcriptional network that regulates B‐cell development and homing, and its activation is essential for germinal center formation and maturation of high‐affinity antibody responses. Such recently discovered inflammasome‐mediated functions in T and B lymphocytes offer multiple cross‐talk opportunities for the innate and adaptive arms of the immune system. A better understanding of the dialog between inflammasomes and intracellular components could be beneficial for therapeutic purposes in restoring immune homeostasis and mitigating inflammation in a wide range of disorders.

Inflammasomes Cross-Talk with Lymphocytes to Connect the Innate and Adaptive Immune Response

Activation and Pharmacological Regulation of Inflammasomes

Swaying the advantage: multifaceted functions of inflammasomes in adaptive immunity

Inflammasome Contribution to the Activation of Th1, Th2, and Th17 Immune Responses

Inflammasome functional activities in B lymphocytes

Inflammasomes: mechanism of action, role in disease, and therapeutics

How Inflammasomes Inform Adaptive Immunity

The Inflammasome NLRs in Immunity, Inflammation, and Associated Diseases

Inflammasome in Dendritic Cells Immunobiology: Implications to Diseases and Therapeutic Strategies

Inflammasome activation: from molecular mechanisms to autoinflammation

Inflammasome activation and Th17 responses.

Inflammasomes as therapeutic targets in human diseases

NLRCs inflammasome subfamilies and their roles in maintaining the balance of normal immune response

Updating the NLRC4 Inflammasome: from Bacterial Infections to Autoimmunity and Cancer

The role of inflammasomes in human diseases and their potential as therapeutic targets

Inflammasomes: Mechanisms of Action and Involvement in Human Diseases

Function of Inflammasomes in Anti-microbial Infections

Inflammasomes and their roles in health and disease

The roles of inflammasomes in cancer

Progress on Activation and Regulation of Inflammasomes

Post-translational Regulation of Inflammasomes